BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 29, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

PAT-SM6: Phase I data

Patrys said tissues analysis of biopsy samples taken from 2 evaluable melanoma patients treated with a single dose of IV PAT-SM6 in an open-label, dose-escalation, Australian Phase I trial suggests that the compound...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >